Share This

Related Topics News -

     
 Detail   |   Print    Next page > 
     
四環醫藥創新藥「達希替尼片」向國家藥監局申報上市並獲受理
2024-05-02T  
四環醫藥三款門冬胰島素系列產品在專項接續採購中獲得擬中選資格
2024-04-25T  
內地嚴厲打擊醫美產品等違法廣告 查處直播營銷違法行為
2024-04-10T  
國家藥監局:射頻皮膚治療儀類產品未取醫療器械註冊證不得生產、進口和銷售
2024-04-02T  
《公司業績》四環醫藥全年虧損收窄至5,401.7萬元人民幣
2024-03-28T  
四環醫藥獨家代理雙波射頻治療儀獲發三類醫療器械註冊證
2024-03-25T  
內地擬成立生物醫藥產業工作組 推進生物醫藥產業數字化轉型
2024-03-12T  
四環醫藥附屬組聯合體中選吉藥預重整投資人
2024-02-08T  
四環醫藥附屬治療糖尿病新藥獲內地上市批准
2024-01-23T  
四環醫藥(00460.HK)聯營北京銳業四款產品獲納入國家醫保目錄
2024-01-10T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.